E.I. duPont De Nemours & Co. v. Florida Evergreen Foliage

744 A.2d 457, 1999 WL 1219961
CourtSupreme Court of Delaware
DecidedDecember 6, 1999
Docket205, 1999
StatusPublished
Cited by82 cases

This text of 744 A.2d 457 (E.I. duPont De Nemours & Co. v. Florida Evergreen Foliage) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
E.I. duPont De Nemours & Co. v. Florida Evergreen Foliage, 744 A.2d 457, 1999 WL 1219961 (Del. 1999).

Opinion

WALSH, Justice:

This Court has accepted a certified question of law from the United States District Court for the Southern District of Florida pursuant to Supreme Court Rule 41(a). The question of law concerns the ability of a litigant who signed a settlement and release of a tort claim to bring suit against the released party for fraudulent inducement. We conclude, in answer to the certified question, that, under Delaware law, a tort claimant fraudulently induced to execute a release may opt either for rescission or a separate suit for fraud with damages calculated on the difference between that received under the release and the value of the settlement or recovery achieved had there been no fraud by the released party.

I.

The factual basis for certification is taken from the District Court for the Southern District of Florida’s Order and Certificate of Question of Law to the Supreme Court of the State of Delaware, dated May 5, 1999. Our certification acceptance is limited to these facts. Kerns v. Dukes, Del.Supr., 707 A.2d 863, 367 (1998).

In October, 1992, Louis Chang and his nursery business, Florida Evergreen Foi-lage, (collectively “Plaintiffs”) brought a products liability action (the “First Suit”) against E.I. duPont de Nemours and Company (“DuPont”) alleging that a DuPont fungicide, Benlate, was defective and that it caused damage to their plants and nursery. In May 1994, Plaintiffs entered into a settlement agreement with DuPont that resulted in DuPont’s payment of $2.3 million in exchange for Plaintiffs executing a release. The preamble of the settlement agreement states:

WHEREAS, Plaintiff has filed suit against Defendant in the civil action identified on Exhibit 1 attached hereto (“the Action”) in which Plaintiff has alleged against Defendant various claims related to Plaintiffs purchase and/or use of Benlate fungicide;
WHEREAS, Defendant has denied the aforementioned allegations;
WHEREAS, Plaintiff desires to terminate said litigation, to release and dispose of all claims against Defendant and all claims incident thereto against Defendant, thereby finally disposing of the same, and to give assurance that Plaintiff will not hereafter prosecute such claims or cause them to be prosecuted.

*459 The settlement agreement also includes the following release language in Paragraph 1:

In consideration of Defendant’s payment of the amount set forth in the authorization previously signed by Plaintiff, Plaintiff hereby releases Defendant from any and all causes of action, claims, demands, actions, obligations, damages, or liability, whether known or unknown, that Plaintiff ever had, now has, or may hereafter have against Defendant, by reason of any fact or matter whatsoever, existing or occurring at any time up to and including the date this Release is signed (including, but not limited to, the claims asserted and sought to be asserted in this action).

Further, the settlement agreement, in Paragraph 15, provides:

This release shall be governed and construed in accordance with the laws of the State of Delaware without giving effect to the choice of laws provisions thereof.

On September 23, 1998", Plaintiffs filed the present action (“Present Action”) for fraudulent inducement in the United States District Court for the Southern District of Florida. In their Amended Complaint, Plaintiffs allege that during the course of the litigation of the First Suit, DuPont wrongfully, illegally, and fraudulently withheld from discovery vital scientific data and information that DuPont was under an obligation to produce in the First Suit and in other Benlate litigation being conducted while the First Suit was pending. Plaintiffs also allege that DuPont gave false testimony in other Benlate cases about the product’s alleged defects and about scientific tests of Benlate relating to such issues. Plaintiffs further allege that the data was material to establishing the allegedly defective and contaminated nature of Benlate. They claim that DuPont withheld this data and information and made false statements in implementation of a scheme to defraud Plaintiffs and others who had used Benlate and suffered resulting damage. Plaintiffs assert that DuPont’s fraudulent conduct began before September 1991 and was continuing as of the filing of the Present Action.

The alleged effect of this scheme and fraud was to induce Plaintiffs to enter into the May 1994 settlement agreement with DuPont for less than they would have otherwise have insisted upon. Plaintiffs allege that, had they known of the concealed data and information, they would have been in a more advantageous position in the First Suit and would have been able to achieve either a judgment in their favor or a more favorable settlement. 1 Plaintiffs have not tendered or paid to DuPont the $2.3 million received as consideration for the release. Plaintiffs allege that before they discovered the fraud, they used the settlement proceeds to pay attorneys’ fees, taxes, Benlate remediation costs, and bank loans, and, as a result, are unable to make an adequate restoration.

The Florida District Court Order of Certification posed the following question: “Under Delaware law, does the release in these settlement agreements bar Plaintiffs’ fraudulent inducement claims?” By order dated May 21, 1999, this Court accepted the certified question.

II.

DuPont contends that the express provisions of the release bar Plaintiffs’ fraudulent inducement claims. Specifically, DuPont argues that Delaware law does not, and should not, recognize settlement fraud based on prior litigation misconduct as an independent cause of action where the parties have agreed to and affirmed a release that includes such claims. DuPont contends that, under Delaware law, the only *460 remedy for a fraudulently induced release is rescission with restoration of the proceeds of the settlement. Because Plaintiffs failed to promptly and unequivocally elect to rescind the contract and make a timely tender of the settlement proceeds upon learning of the facts giving rise to the alleged fraud, DuPont asserts that Plaintiffs are foreclosed from pursuing such remedy.

Plaintiffs contend that the release does not cover the conduct alleged in the Present Action. They argue that the language of the release makes it clear that the parties were settling a products liability claim based on damage to Plaintiffs’ plants and business arising from the use of a defective product and not damages attributable to DuPont’s fraudulent conduct which, Plaintiffs claim, was unknown at the time and completely unrelated. Moreover, Plaintiffs argue that any clause in the release interpreted to bar Plaintiffs’ fraud action would be unconscionable, against public policy, and unenforceable.

Plaintiffs contend that under the election of remedies doctrine they need not rescind the settlement agreement to bring the Present Action for Fraud against DuPont. However, as an alternative remedy, Plaintiffs have asked that the release be rescinded, despite the concession that they have yet to make a timely tender of the settlement consideration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sands v. Homestar Remodeling, LLC.
Superior Court of Delaware, 2025
GPC3 I, LLC v. Javarone
S.D. Florida, 2025
JanCo FS 2, LLC v. ISS Facility Services, Inc.
Superior Court of Delaware, 2025
Ulrich v. O'Keefe
S.D. New York, 2025
Wright v. SLWM, LLC
Court of Chancery of Delaware, 2025
Michael Blue v. Tilray Brands, Inc.
Court of Chancery of Delaware, 2025
Garnett v. Cote
Superior Court of Delaware, 2025
Everphone, Inc. v. Go Technology Management, LLC
Superior Court of Delaware, 2023
Baker v. Croda Inc.
Supreme Court of Delaware, 2023
NetApp, Inc. v. Albert E. Cinelli
Court of Chancery of Delaware, 2023
Gilbert J. Menna v. Andrew J. Weidhaas
Court of Chancery of Delaware, 2023
Pimpaktra A. Rust v. Vina Elise Rust
Court of Chancery of Delaware, 2023
Medlink Health Solutions, LLC v. JL Kaya, Inc.
Superior Court of Delaware, 2023

Cite This Page — Counsel Stack

Bluebook (online)
744 A.2d 457, 1999 WL 1219961, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ei-dupont-de-nemours-co-v-florida-evergreen-foliage-del-1999.